A Study in Healthy Adult Male Participants to Assess Absorption, Distribution, Metabolism and Excretion (ADME) of Radiolabeled PF-06865571.

Inclusion Criteria: * Male participants, 18 to 60 years of age, inclusive, at the time of signing the informed consent document. * Male participants who are overtly healthy as determined by medical evaluation including medical history, physical examination, laboratory tests, and cardiac tests. * Participants who are nonsmoking for at least 3 months at the time of signing the informed consent document. * BMI of 17.5 to 30.4 kg/m2, inclusive; and a total body weight \>50 kg (110 lb). Exclusion Criteria: * Any condition possibly affecting drug absorption (eg, gastrectomy, cholecystectomy). * History of irregular bowel movements including irritable bowel syndrome or frequent episodes of diarrhea or constipation, defined by less than 1 bowel movement on average per 2 days, or lactose intolerance. * History of HIV infection, hepatitis B, or hepatitis C; positive testing for HIV, HBsAg,or HCVAb. Hepatitis B vaccination is allowed. * History of SARS-CoV-2 PCR or antibody (eg, IgG, IgM, etc) positive result would necessitate accompanying history of asymptomatic state for at least 6 months prior to screening. * Use of prescription or nonprescription drugs. * Previous administration with an unapproved drug within 60 days preceding the first dose of study intervention used in this study. * A positive urine drug test. * A positive urine cotinine test. * A positive COVID-19 (SARS-CoV-2) PCR test. * Blood donation (excluding plasma donations) of approximately 1 pint (500 mL) or more with…